| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/22/1999 | CA2318660A1 Lh-receptor gene promoter for tissue-specific gene expression |
| 07/22/1999 | CA2318575A1 Feline immunodeficiency virus gene therapy vectors |
| 07/22/1999 | CA2318498A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | CA2318493A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | CA2318402A1 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | CA2318358A1 Polypeptides, dna coding therefor, formulations thereof, and their use in inhibiting factor xii activation |
| 07/22/1999 | CA2318156A1 Mmsc1 - an mmac1 interacting protein |
| 07/22/1999 | CA2317941A1 Adenoviral vectors with modified capsid proteins |
| 07/22/1999 | CA2317934A1 Novel promoter elements for persistent gene expression |
| 07/22/1999 | CA2317895A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | CA2317815A1 Neisseria meningitidis antigens |
| 07/22/1999 | CA2315299A1 Fatty acid synthase mrna binding protein |
| 07/21/1999 | EP0929689A2 Artifical chromosomes, uses thereof and methods for preparing artificial chromosomes |
| 07/21/1999 | EP0929688A1 Sustained delivery device and methods of making and using the same |
| 07/21/1999 | EP0929687A1 Mammary gland-specific promoters |
| 07/21/1999 | EP0929679A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 07/21/1999 | EP0929675A2 Nucleotide and protein sequence of mammastatin and methods of use |
| 07/21/1999 | EP0929674A2 HUMAN Bad POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929671A1 Method for treating amyotrophic lateral sclerosis |
| 07/21/1999 | EP0929664A1 Hematopoietic stem cells and methods for generating such cells |
| 07/21/1999 | EP0929575A1 Novel human growth factors |
| 07/21/1999 | EP0929536A1 Piperazine based cytofectins |
| 07/21/1999 | EP0929318A2 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 07/21/1999 | EP0929311A1 INHIBITION OF APOPTOSIS USING INTERLEUKIN-1 beta-CONVERTING ENZYME (ICE)/CED-3 FAMILY INHIBITORS |
| 07/21/1999 | EP0929306A1 Method of inhibiting smooth muscle cell proliferation |
| 07/21/1999 | CN1223690A Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 07/21/1999 | CN1223685A Modulators of tissue regeneration |
| 07/21/1999 | CN1223660A Method and compounds for curing diseases caused by mutations |
| 07/20/1999 | US5925802 Functional reconstitution of SCID-bo mice with bovine fetal hematopoietic tissues |
| 07/20/1999 | US5925733 DNA polymerase of gamma herpes viruses associated with Kaposi's sarcoma and retroperitoneal fibromatosis |
| 07/20/1999 | US5925729 Isolated amino acid sequence encoding antigen; use as agent for treating the cancer for which the antigen is a ?marker?, as well as in various diagnostic approaches to oncology |
| 07/20/1999 | US5925566 Signal transduction polypeptide with two zinc finger domains; binds to epidermal growth factor receptor and released after activation to localize in nucleolus; anticarcinogenic agents; angiogenesis inhibitors |
| 07/20/1999 | US5925565 Internal ribosome entry site, vector containing it and therapeutic use |
| 07/20/1999 | US5925564 Expression vector systems and method of use |
| 07/20/1999 | US5925557 This invention relates generally to the field of protein kinases, oncogenes and oncoproteins and, specifically, to a protein kinase which phosphorylates and potentiates the activity of c-fos. |
| 07/20/1999 | US5925547 Nucleic acid encoding novel protein domain which binds tyrosine phosphorylated proteins |
| 07/20/1999 | US5925539 Human pelota homolog |
| 07/20/1999 | US5925333 Screening for compounds that alter the binding by scavengers |
| 07/16/1999 | WO1999036510A1 Efficient nuclear transfer using fetal fibroblasts |
| 07/15/1999 | WO1999035495A2 Identification of substances that modify cellular secretory function |
| 07/15/1999 | WO1999035292A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | WO1999035277A2 Recombinant, active caspases and uses thereof |
| 07/15/1999 | WO1999035266A2 Human urotensin ii |
| 07/15/1999 | WO1999035255A2 Compositions and methods for regulated secretion from neuroendocrine cell lines |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035245A2 Methods for preparing and using immortalized human neuroendocrine cells |
| 07/15/1999 | WO1999035243A2 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | WO1999035242A1 Media for neuroendocrine cells |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999034837A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | WO1999034836A1 Methods of controlling cell differentiation and growth using a fusion protein and a drug |
| 07/15/1999 | WO1999034835A1 Gene therapy of tumors using non-viral delivery system |
| 07/15/1999 | WO1999034834A1 Use of pigmented retinal epithelial cells for creation of an immune privilege site |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034818A1 Broad spectrum chemokine antagonist and uses thereof |
| 07/15/1999 | WO1999034804A1 A2a adenosine receptor agonists |
| 07/15/1999 | WO1999029729A3 Antagonists of neuropilin receptor function and use thereof |
| 07/15/1999 | WO1999028466A8 Compositions and methods of use of het |
| 07/15/1999 | WO1999025837A3 Method for producing virus-like particles on the basis of polyoma viruses |
| 07/15/1999 | WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 07/15/1999 | WO1999023215A3 Materials and methods for preventing cellular injury in humans and animals |
| 07/15/1999 | WO1999021992A9 Nucleic acid molecules encoding a glutamate receptor |
| 07/15/1999 | WO1998042855A9 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 07/15/1999 | CA2321972A1 Gene therapy of tumors using non-viral delivery system |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2318380A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | CA2318379A1 Identification of substances that modify cellular secretory function |
| 07/15/1999 | CA2318376A1 Compositions and methods for regulated secretion from neuroendocrine cell lines |
| 07/15/1999 | CA2318369A1 Recombinant, active caspases and uses thereof |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317093A1 A2a adenosine receptor agonists |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2315708A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | CA2315265A1 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928339A1 Mammalian artificial chromosomes |
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928290A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/14/1999 | EP0928202A1 Non-invasive administration of adeno-associated viral vectors |
| 07/14/1999 | EP0928190A2 Nucleic acid particle delivery |
| 07/14/1999 | EP0928135A1 System for enhancing cardiac signal sensing by cardiac pacemakers through genetic treatment |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/13/1999 | US5922927 Methods for producing tetracycline-regulated transgenic mice |
| 07/13/1999 | US5922859 Complexes containing nucleic acid which can be taken-up by endocytosis into higher eukaryotic cells |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922844 Human cAMP-dependent protein kinase inhibitor homolog |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922688 Administering polyomavirus enhancer activator (pea3) to inhibit a transformed phenotype; treating neu-mediated cancer |
| 07/13/1999 | US5922687 Placing the nucleic acid in an extracellular environment of the cell, defining an enclosure comprising the cell and the extracellular environmenat, establishing an incubation pressure within the enclosure; useful for gene therapy |
| 07/13/1999 | US5922686 Nucleotide sequences and hybridization and protein c and kinases |
| 07/13/1999 | US5922685 IL-12 gene therapy of tumors |
| 07/13/1999 | US5922676 Superfibronectin prevents tumor cell metastasis, tumor cell migration and growth by administering to the patient an effective amount of superfibronectin |
| 07/13/1999 | US5922590 Hic-1 is a marker which can be used diagnostically, prognostically and therapeutically over the course of such disorders. |
| 07/13/1999 | US5922572 Polynucleotides encoding haemopoietic maturation factor |
| 07/13/1999 | US5922562 Nucleic acids encoding transferrin receptors |